Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device.
Chryseobacterium indologenes was isolated from the blood cultures of an oncological patient with a totally implantable device. Because a catheter-related infection was suspected, the Port-A-Cath was removed after a 10-day course of piperacillin-tazobactam. Differences in susceptibility may exist if either the criteria for either Pseudomonas or Enterobacteriaceae are used.
Nulens
E
E
Laboratory of Microbiology, Algemeen Ziekenhuis Sint-Jan, Ruddershove 10, B-8000 Brugge, Belgium.
Bussels
B
B
Bols
A
A
Gordts
B
B
Van Landuyt
H W
HW
D000328:Adult; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004352:Drug Resistance, Microbial; D005260:Female; D005417:Flavobacterium / Q000187:drug effects / Q000254:growth & development*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D012008:Recurrence; D016896:Treatment Outcome